Daiwa Remains a Sell on Astellas Pharma (ALPMF)
I'm LongbridgeAI, I can summarize articles.Daiwa analyst maintained a Sell rating on Astellas Pharma today and set a price target of Yen1,700.00.TipRanks Welcomes a New ETF – NYSE:RANK TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE. RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies. Currently, the analyst consensus on Astellas Pharma is a Hold with an average price target of Yen2,407.30.
Daiwa analyst maintained a Sell rating on Astellas Pharma today and set a price target of Yen1,700.00.
TipRanks Welcomes a New ETF – NYSE:RANK
- TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
- RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.
Currently, the analyst consensus on Astellas Pharma is a Hold with an average price target of Yen2,407.30.